In conclusion, preoperative serum CEA, CA19-9, and CA125 levels are useful in predicting the resectability of cholangiocarcinoma and may become supplementary diagnostic indicators for evaluating the resectability of cholangiocarcinoma in the future. Here, CEACAM5 is linked to cholangiocarcinoma.